Add BrightSurf on Google Email

Men with low or high testosterone may have higher risk of irregular heartbeat

A review of existing evidence on testosterone and heart health found that both low and high testosterone levels increase the risk of atrial fibrillation. The risk appears to follow a U-shaped pattern, with the lowest risk in the middle of the normal testosterone range. This suggests that treatment should be individualized and monitored.

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateSep 1, 2026

Endocrine-disrupting chemical exposure may be linked to high blood pressure during pregnancy

A recent study published in the Journal of the Endocrine Society suggests a link between exposure to phthalates and elevated blood pressure during pregnancy. Pregnant women with higher levels of fragrance-associated phthalates were found to have higher systolic and diastolic blood pressure markers, increasing their risk of hypertensive...

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateAug 10, 2026

Lancet definition vs other criteria for obesity diagnosis in adults

The Lancet Diabetes and Endocrinology Commission on Obesity definition of obesity was found to have similar diagnostic accuracy as other definitions. The study compared the commission's definition with those from other reputable sources, including the World Health Organization (WHO) and the National Institutes of Health (NIH).

SourceJAMA Network·JournalJAMA Network Open·DateAug 7, 2026

Hidden hormone–habitat relationship revealed in reef fish

Researchers discovered a strong link between environmental variation and thyroid hormone signaling in reef fish, enabling them to adapt to changing habitats. The study found that habitat impacts development by altering gene expression and metabolic profiles, giving animals more flexibility when their environments change.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalScience Advances·TypeExperimental study·DateAug 7, 2026

Growth hormone therapy helps childhood stem cell transplant survivors grow taller, but responses vary widely

A Japan-wide study found that growth hormone therapy improves adult height in childhood stem cell transplant survivors with short stature. However, treatment responses were highly variable and influenced by transplant-related factors such as total body irradiation and chronic graft-versus-host disease.

SourceHiroshima University·JournalFrontiers in Endocrinology·TypeData/statistical analysis·DateAug 7, 2026

Type 1 diabetes incidence and prevalence in the US

A cross-sectional study examines state-level type 1 diabetes burden and pediatric endocrinology resource distribution in the US. The study found that type 1 diabetes incidence has increased over time, while pediatric endocrinology resources are not evenly distributed across states.

SourceJAMA Network·JournalJAMA Network Open·DateAug 7, 2026

New position statement calls for systematic bone health optimization before joint replacement and spinal fusion surgery

A new position statement calls for systematic bone health optimization before joint replacement and spinal fusion surgery. Key findings include the progressive mechanical failure of bone-implant constructs resulting from compromised bone quality, particularly due to osteoporosis.

SourceInternational Osteoporosis Foundation·JournalOsteoporosis International·TypeLiterature review·DateJul 20, 2026

Chonnam National University researchers reveal isoform-specific HIF signaling in skeletal muscles

Mouse study uncovers how oxygen-sensing transcription factors regulate muscle physiology, improving glucose tolerance and producing erythropoietin. The findings suggest that selectively targeting each isoform can lead to different physiological outcomes.

SourceChonnam National University, The Research Information Management Team, Office of Research Promotion·JournalJournal of Clinical Investigation·TypeExperimental study·DateJul 13, 2026

Breakthrough treatment for weight dysregulation after brain tumors

A clinical trial has shown that setmelanotide, a new drug, can achieve significant weight loss in people whose weight has become dysregulated following treatment for a brain tumor. The treatment resulted in a 20% reduction in BMI, with participants experiencing substantial health benefits.

SourcePrincess Máxima Center for Pediatric Oncology·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJul 8, 2026

Not all children with early puberty need the same level of testing or treatment

Children who start puberty earlier than usual may not need the same level of testing or treatment, according to a new Endocrine Society Clinical Practice Guideline. The guideline suggests different approaches for various subgroups, including monitoring girls with slow progression and using simpler testing methods.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJun 13, 2026

Mount Sinai opens Carolyn Rowan Center for Women’s Health and Wellness, a new model of coordinated care across the lifespan

The Mount Sinai Health System has opened the Carolyn Rowan Center for Women’s Health and Wellness, which brings together multidisciplinary clinical expertise, structured care pathways, and leading-edge research to deliver personalized, comprehensive care for women. The Center offers guided multi-visit experiences and coordinated care o...

Targeted therapy improves mobility in children with rare bone disorder

A phase 2 clinical trial found that burosumab safely restored normal phosphate levels and improved physical function in patients with severe fibrous dysplasia. Key findings include reduced pain, fatigue, and mobility impairment, as well as significant improvements in children's mobility and independence.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalBone Research·TypeRandomized controlled/clinical trial·DateMay 20, 2026

International experts call for end to routine reporting of “corrected” calcium

International experts in laboratory medicine, osteoporosis, and chronic kidney disease recommend ending routine reporting of albumin-adjusted ('corrected') calcium. The practice may misclassify patients and compromise care due to unreliable correction formulas and variability in local measurements.

SourceInternational Osteoporosis Foundation·JournalClinical Chemistry and Laboratory Medicine (CCLM)·TypeCommentary/editorial·DateMay 18, 2026

Paraprobiotic counteracts damage to male fertility from BPA in plastic

A recent study published in Journal of Functional Foods found that paraprobiotics derived from Enterococcus faecalis FK-23 can protect against sperm toxicity caused by bisphenol A (BPA) exposure. The researchers observed improved sperm motility and reduced oxidative stress markers when rats received FK-23 despite BPA exposure.

SourceOsaka Metropolitan University·JournalJournal of Functional Foods·TypeExperimental study·DateMay 15, 2026

The 28th European Congress of Endocrinology (ECE) hosts the largest gathering of endocrine specialists in Europe

The 28th European Congress of Endocrinology (ECE) 2026 brought together over 4,500 delegates from 111 countries to experience the latest endocrine research and developments. The Congress celebrated the Society's 20th Anniversary and featured groundbreaking studies on hormone disruption, bone development, insulin resistance, and polycys...

Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a complex hormonal disorder impacting 1 in 8 women globally, affecting weight, metabolism, mental health, skin, and the reproductive system. The name change aims to improve diagnosis and care for this previously misunderstood condition.

SourceMonash University·JournalThe Lancet·TypeMeta-analysis·DateMay 12, 2026